Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares

▤ Summary

Lobe Sciences says its directors and management settled C$1.37 million in accrued fees by taking common shares instead of cash. The move increases insider ownership to more than 40% and keeps management aligned with shareholders. The company also highlights a strong cash position and continued progress across its subsidiary drug development programs. Lobe frames the equity settlement as part of its broader strategy to preserve capital while advancing clinical and regulatory milestones.

▦ Linked Companies